MedTrace Logo

Mesenchymal Stem Cells to Treat Ischemic Cardiomyopathy

NCT01913886 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-12-13

No results posted yet for this study

Summary

This study will evaluate the safety and efficacy of intracoronary injection of mesenchymal stem cells (MSCs) to repair heart function in patients with myocardial ischemia.

Conditions

  • Ischemic Cardiomyopathy

Interventions

PROCEDURE

MSCs injection

MSCs cells will be injected in two aliquots of 10 ml by catheterism

Sponsors & Collaborators

  • Santa Casa de Misericórdia de Curitiba, Brazil

    collaborator UNKNOWN

  • Fundação Araucária

    collaborator OTHER

  • Alexandra Cristina Senegaglia

    lead OTHER

Principal Investigators

  • Paulo Brofman, PhD · Pontifícia Universidade Católica do Paraná

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-09-30
Completion
2016-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01913886 on ClinicalTrials.gov